Laboratorios Farmaceuticos Rovi Financial Overview
Laboratorios Farmaceuticos Rovi's market cap is currently €3.14B. The company's EPS TTM is €1.134; its P/E ratio is 26.22; and it has a dividend yield of 1.51%. Laboratorios Farmaceuticos Rovi is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
